Attachment F to CPRIT Contract
EXHIBIT 10.1
PORTIONS HEREIN IDENTIFIED BY [*****] HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE EXCLUDED INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
Grant ID: DP160012 | PI/PD/CR: Jeff Hutchins |
No Cost Extension with Attachment F
As indicated by the signatures below, the INSTITUTE and the RECIPIENT agree to the following amendments to the CPRIT Contract:
Original Contract End Date: 31 May 2019
Current Contract End Date: 31 May 2019
Proposed Contract End Date: 30 Nov 2019
Justification: [*****].
Contract Document F: Parties hereby agree that the RECIPIENT is granted a six-month extension of time from the date of the original
contract termination date reflected in Section 2.03 of the Contract, for purposes of concluding the approved scope of work as authorized by
the Contract. Accordingly, the May 31, 2019 termination date is deleted in Section 2.03 and replaced with November 30, 2019. All terms
and conditions of the Contract continue during the extension period. Parties agree that this extension is a “no-cost” extension and approval of
this amendment does not approve, grant or confer additional grant funds in excess of the amount originally awarded.
Description: The May 31, 2019 termination date is deleted in Section 2.03 and replaced with November 30, 2019.
RECIPIENT Pelican Therapeutics ASO Name: Jasuja, Rahul Submitted Date: 06 Mar 2019 | INSTITUTE Cancer Prevention & Research Institute of Texas CEO Name: Roberts, Wayne Approved Date: 12 Apr 2019 |
